What is vaginal metronidazole used for? Vaginal metronidazole is an antibiotic that is commonly used for an infection called bacterial vaginosis that is caused by certain bacteria. Vaginal ...

Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

The drug is available in several forms: immediate-release oral tablets and capsules extended-release oral tablets topical creams, gels, and lotions vaginal gels The different forms of ...

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% ...

Metronidazole vaginal gel 0.75% to launch immediately -- BRIDGEWATER, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris”) announced today that the U.S. Food and Drug ...

The generic name of the gel is Metronidazole Vaginal Gel. "Metronidazole vaginal gel is a widely used antibacterial preparation, and its generic version can bring significant savings to the ...

and metronidazole vaginal gel. Notably, more than half of the study cohort used probiotics, i.e., either oral Lactobacillus sp or intravaginally administered, and one-third received vaginal boric ...

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.

Annual market sales for MetroGel-Vaginal® for the 12 months ending May 2019 were approximately $100 million as measured by IQVIA™. The product is manufactured by Perrigo and was developed ...

DUBLIN and LAVAL, Quebec, March 25, 2014 /CNW/ - Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug ...

DUBLIN, July 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug Administration for ...